Latest Breaking News On - Office of pharmacy affairs - Page 7 : vimarsana.com

To embed, copy and paste the code into your website or blog: On December 14, 2020, the U.S. Health Resources and Services Administration (HRSA) published a final rule (Final Rule) in the Federal Register defining an administrative dispute resolution (ADR) process for the 340B Drug Pricing Program (340B Program). The Final Rule takes effect 30 days after that date of publication, on January 13, 2021. The Final Rule establishes an ADR process for two types of disputes: “Claims by covered entities that may have been overcharged for covered outpatient drugs purchased from manufacturers”; and “Claims by manufacturers of 340B drugs, after a manufacturer has conducted an audit of a covered entity . . . . that a covered entity may have violated the prohibitions against duplicate discounts [i.e., that a Medicaid rebate was invoiced for a drug purchased at the 340B ceiling price] or diversion [i.e., that the covered entity transferred 340B drugs to a person that is not a 340B ‘patie

White houseDistrict of columbiaUnited statesSanta clara ctyHogan lovellsCenters for medicare medicaid servicesUs health resourcesHuman servicesB programOffice of pharmacy affairsUs supreme courtSee astra united states incAgency decisionServices administrationHealth ctrsB drug pricing program